Texto: 
pe:  pelvic mass  (especially on bimanual under anesthesia)	                 
                                    
lab: ua - gross hematuria, malignant cytology
superficial (carcinoma in situ):
endoscopic resection with f/u q3-6 mos
recurrence: laser therapy or intravesical thiotepa, doxorubicin, mitomycin, or bcg.

invasive (extension into muscle or perivesical fat): 
cystectomy
radiation treatment

metastatic (grim prognosis):
chemotherapy: cisplatin, methotrexate, doxorubicin, cyclophosphomide, vinblastine
kub:  punctate, coarse linear calcifications encrusted on surface or within tumor located in the bladder region suggests malignancy.
carcinoma of the bladder
73yo african american male with gross hematuria, otherwise asymptomatic
demographics: men 3x's > women
60-70 years old

associated with the following:
1.) exposure to aromatic amines
(2-naphthylamine)
dye, chemical, rubber industries
2.)  smokers
3.)  recurrent nephrolithiasis
4.)  recurrent uti's
5.)  travel/residence in middle east
chronic schistosomial infections

present with the following symptoms:

1.) gross hematuria (75% of patients) dysuria
2.) frequency
3.) urgency (25% of patients)
4.) pelvic and/or flank pain
5.) visceral or osseous pain from metastasis


Keywords by value: 
- :: 0.05756029155508016
- doxorubicin: 0.05718945457732629
- gross: 0.05653592077226733
- hematuria: 0.056296451238454746
- ): 0.05615805910151012
- q3-6: 0.04081258529614119
- thiotepa: 0.04081258529614119
- cyclophosphomide: 0.04081258529614119
- 73yo: 0.04081258529614119
- aromatic: 0.04081258529614119
- amines: 0.04081258529614119
- 2-naphthylamine: 0.04081258529614119
- industries: 0.04081258529614119
- uti's: 0.04081258529614119
- travel/residence: 0.04081258529614119
- schistosomial: 0.04081258529614119
- intravesical: 0.037603570571326635
- encrusted: 0.037603570571326635
- rubber: 0.037603570571326635
- mitomycin: 0.03572641729304809
- perivesical: 0.03572641729304809
- 3x: 0.03572641729304809
- dye: 0.03572641729304809
- bcg: 0.03439455584651207
- grim: 0.03439455584651207
- east: 0.03439455584651207
- recurrent: 0.03338918769560257
- vinblastine: 0.033361483849687026
- cisplatin: 0.03251740256823353
- pelvic: 0.032474543764493456
- bladder: 0.03211491567823175
- cystectomy: 0.03180374201347771
- 60-70: 0.03180374201347771
- smokers: 0.030640249289954992
- urgency: 0.028937819752337782
- mos: 0.028594727288663146
- demographics: 0.028594727288663146
- bimanual: 0.028275315846593922
- laser: 0.027976526396882945
- cytology: 0.026717574010384604
- anesthesia: 0.02629640837054328
- visceral: 0.02629640837054328
- kub: 0.025910382403232856
- situ: 0.02572880502752322
- dysuria: 0.02572880502752322
- methotrexate: 0.025223252749907516
- f/u: 0.024625050289351934
- chemical: 0.024352640567023538
- (: 0.023409870757902886
- coarse: 0.023399621797559885
- endoscopic: 0.02329318884281591
- nephrolithiasis: 0.02329318884281591
- or: 0.02318339696675249
- 5: 0.02314963354114966
- punctate: 0.023087393645728718
- following: 0.022456275526862482
- carcinoma: 0.022425256203850615
- men: 0.022345066562047333
- 4: 0.02204603615906523
- superficial: 0.021143625842208975
- ua: 0.02101320511551131
- frequency: 0.020886358012788556
- african: 0.020642637024430123
- exposure: 0.020583660053238317
- patients: 0.02047754258672246
- 75: 0.02024475540498232
- invasive: 0.019878378920914156
- suggests: 0.019778813156002287
- lab: 0.019355506646929917
- women: 0.019222589490066812
- american: 0.01884530692408911
- 1: 0.018827095999626915
- infections: 0.018805223300278395
- prognosis: 0.01876548374615158
- flank: 0.018609851288748872
- 3: 0.0185275511732087
- %: 0.018456676234685256
- pe: 0.01777215130345335
- surface: 0.017463394940033572
- under: 0.01728756508787979
- recurrence: 0.017258898558954232
- 2: 0.01703800459731987
- osseous: 0.01679691026910066
- linear: 0.0167711183938717
- and/or: 0.016719961744859735
- especially: 0.016283338228789173
- located: 0.016283338228789173
- 25: 0.015991788232671632
- malignancy: 0.015287452212044054
- ,: 0.015039448084293743
- metastasis: 0.014809015399536697
- calcifications: 0.014709091456633112
- middle: 0.014468328563159433
- malignant: 0.0142994012795338
- muscle: 0.014209792747344189
- otherwise: 0.014209792747344189
- chemotherapy: 0.014180304560837338
- extension: 0.014121885746211357
- asymptomatic: 0.013373112953685588
- >: 0.013144294049391502
- radiation: 0.012982644673899705
- resection: 0.012337572479260272
- fat: 0.012032001494822376
- years: 0.011616866375085567
- region: 0.011174079755737558
- chronic: 0.011143470522717592
- therapy: 0.010577040723336172
- metastatic: 0.009958839831555972
- symptoms: 0.009859525356009903
- pain: 0.009663038588247543
- into: 0.009413547999813457
- associated: 0.009335474823646767
- tumor: 0.009223297692642645
- present: 0.00893522571264667
- 's: 0.008722438047995579
- -: 0.008480224345872053
- treatment: 0.00800748592407818
- within: 0.007546904668454081
- male: 0.007153729342071635
- on: 0.006702694558939149
- from: 0.0058631283016398715
- in: 0.00585273930750354
- mass: 0.00550213429142391
- old: 0.004050623133621549
- the: 0.002560171938956033
- with: 0.0021667440016646246
- to: 0.001977167168717529
- .: 0.001972196449852571
- of: 0.0016181083444165058
